NEWS BRIEF · Research journal
A novel candidate biomarker for detecting premalignant and early ovarian cancer
From the report
Nature Medicine, Published online: 10 November 2026; doi:10.1038/s41591-026-04755-2New data suggest that the long noncoding RNA known as Tu-Stroma represents a promising new circulating biomarker for the detection of ovarian cancer at premalignant and early stages, for which sensitive screening methods currently are lacking.
